Download the PDF: "Alzheimer's: the numbers we cannot forget"

Consultant David Cooney explores the success rate of trials in Alzheimer's Disease and current treatments.


In the last 13 years, only one new drug has been approved for patients with Alzheimer's Disease. The most recently approved drug was in 2014, bringing the total number of agents approved across AD to 5.

In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as look at the some of the glimmers of light at the end of the tunnel.

Please enter your details so we can email you the content:

Sign up for our newsletters to receive...